Preclinical News and Research

RSS
Stress response proteins offer a promising target for a novel drug guidance system

Stress response proteins offer a promising target for a novel drug guidance system

Certain cancers might one day be cured without the use of toxic chemotherapy and radiation

Certain cancers might one day be cured without the use of toxic chemotherapy and radiation

Potential stem cells treatment for retinitis pigmentosa and other retinal degenerations

Potential stem cells treatment for retinitis pigmentosa and other retinal degenerations

Potential new drug for the treatment of sickle cell disease

Potential new drug for the treatment of sickle cell disease

Gene therapy holds much promise for treating aggressive human superficial bladder cancer

Gene therapy holds much promise for treating aggressive human superficial bladder cancer

Sinovac completes dosing in phase 1 human clinical testing of SARS vaccine

Sinovac completes dosing in phase 1 human clinical testing of SARS vaccine

Stopping bacteria from talking to each other could help prevent serious infections

Stopping bacteria from talking to each other could help prevent serious infections

University of Nottingham research developments could mean new drugs will reach cancer patients more quickly

University of Nottingham research developments could mean new drugs will reach cancer patients more quickly

New drug application for exenatide has been accepted for review

New drug application for exenatide has been accepted for review

Interim data from human clinical trials of two AIDS vaccine candidates, named DNA.HIVA and MVA.HIVA

Interim data from human clinical trials of two AIDS vaccine candidates, named DNA.HIVA and MVA.HIVA

Kiwis reverse heart disease in diabetics

Kiwis reverse heart disease in diabetics

New study confirms benefits of rimonabant in weight loss

New study confirms benefits of rimonabant in weight loss

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Dual-action compound shows promise in killing prostate cancer cells

Dual-action compound shows promise in killing prostate cancer cells

Corkscrew-like device that removes blood clots from the brains of stroke sufferers

Corkscrew-like device that removes blood clots from the brains of stroke sufferers

Study on RNAi technology targeting neurodegenerative diseases

Study on RNAi technology targeting neurodegenerative diseases

No adverse side-effects have been observed in clinical trial of SARS vaccine

No adverse side-effects have been observed in clinical trial of SARS vaccine

Clinical trial of lipase inhibitor for the treatment of obesity

Clinical trial of lipase inhibitor for the treatment of obesity

Second case of variant Creutzfeldt-Jakob disease infection that was probably caused by blood transfusion

Second case of variant Creutzfeldt-Jakob disease infection that was probably caused by blood transfusion

Promising new cancer drug, Nanotax

Promising new cancer drug, Nanotax

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.